1. Developmental Biology
  2. Genetics and Genomics

Affinity-tagged SMAD1 and SMAD5 mouse lines reveal transcriptional reprogramming mechanisms during early pregnancy

  1. Zian Liao
  2. Suni Tang
  3. Kaori Nozawa
  4. Keisuke Shimada
  5. Masahito Ikawa
  6. Diana Monsivais  Is a corresponding author
  7. Martin Matzuk  Is a corresponding author
  1. Department of Pathology & Immunology, Baylor College of Medicine, United States
  2. Graduate Program of Genetics and Genomics, Baylor College of Medicine, United States
  3. Department of Molecular and Human Genetics, Baylor College of Medicine, United States
  4. Center for Drug Discovery, Baylor College of Medicine, United States
  5. Research Institute for Microbial Diseases, Osaka University, Japan
https://doi.org/10.7554/eLife.91434.4
Share this article
Cite this article
  1. Zian Liao
  2. Suni Tang
  3. Kaori Nozawa
  4. Keisuke Shimada
  5. Masahito Ikawa
  6. Diana Monsivais
  7. Martin Matzuk
(2024)
Affinity-tagged SMAD1 and SMAD5 mouse lines reveal transcriptional reprogramming mechanisms during early pregnancy
eLife 12:RP91434.
https://doi.org/10.7554/eLife.91434.4
  2. Download BibTeX
  3. Download .RIS

eLife assessment

This study presents two valuable new mouse models that individually tag proteins from the SMAD family to identify distinct roles during early pregnancy. Convincing evidence is provided that SMAD1 and SMAD5 target many of the same genomic regions as each other and the progesterone receptor. Given the broad effect of these signaling pathways in multiple systems, these new tools will most likely interest readers across biological disciplines.

https://doi.org/10.7554/eLife.91434.4.sa0

Abstract

Endometrial decidualization, a prerequisite for successful pregnancies, relies on transcriptional reprogramming driven by progesterone receptor (PR) and bone morphogenetic protein (BMP)-SMAD1/SMAD5 signaling pathways. Despite their critical roles in early pregnancy, how these pathways intersect in reprogramming the endometrium into a receptive state remains unclear. To define how SMAD1 and/or SMAD5 integrate BMP signaling in the uterus during early pregnancy, we generated two novel transgenic mouse lines with affinity tags inserted into the endogenous SMAD1 and SMAD5 loci (Smad1HA/HA and Smad5PA/PA). By profiling the genome-wide distribution of SMAD1, SMAD5, and PR in the mouse uterus, we demonstrated the unique and shared roles of SMAD1 and SMAD5 during the window of implantation. We also showed the presence of a conserved SMAD1, SMAD5, and PR genomic binding signature in the uterus during early pregnancy. To functionally characterize the translational aspects of our findings, we demonstrated that SMAD1/5 knockdown in human endometrial stromal cells suppressed expressions of canonical decidual markers (IGFBP1, PRL, FOXO1) and PR-responsive genes (RORB, KLF15). Here, our studies provide novel tools to study BMP signaling pathways and highlight the fundamental roles of SMAD1/5 in mediating both BMP signaling pathways and the transcriptional response to progesterone (P4) during early pregnancy.

Introduction

Infertility is an emerging health issue that affects approximately 15% of couples (Boivin et al., 2007). One in five women aged 15–49 years old with no prior births suffers from infertility in the United States (Martinez et al., 2018). One important factor affecting fertility is failed embryo implantation or subsequent post-implantation loss due to endometrial defects. This is evident from the high number of failed pregnancies, with as many as 15% of pregnancies resulting in early pregnancy losses (Wang et al., 2003). Understanding the molecular mechanism of how the maternal endometrium becomes suitable for embryo implantation and eventual decidualization will be the key to eradicating global concerns related to infertility and early pregnancy losses.

The transforming growth factor β (TGFβ) family plays diverse roles in development, physiology, and pathophysiology (Chang et al., 2002; Monsivais et al., 2017b), and in particular, signaling pathways downstream of the bone morphogenetic protein (BMP) subfamily are essential for decidual formation (Lee et al., 2007; Monsivais et al., 2017a). There are more than 30 TGFβ family ligands, and these ligands signal through complexes of transmembrane type 1 activin-like kinase (ALK) receptors (ALK1, ALK2, ALK3, ALK6) and transmembrane type 2 receptors (BMPR2, ACVR2A, ACVR2B) and then phosphorylate downstream SMAD1 and SMAD5 proteins. Phosphorylated SMAD1/5 form heteromeric complexes with SMAD4 and translocate to the nucleus to induce specific transcriptional programs. Our laboratory and others have used genetically engineered mouse models with deletions of ligands, receptors, and downstream effectors of BMP signaling pathways to establish that BMP signaling pathways are major regulators of early pregnancy (Lee et al., 2007; Monsivais et al., 2017a; Nagashima et al., 2013; Monsivais et al., 2021; Matzuk et al., 1995; Clementi et al., 2013; Monsivais et al., 2016).

A successful pregnancy begins with reciprocal crosstalk between the maternal endometrium and the new blastocyst during the peri-implantation window. Effective implantation requires precise synchronization between the development of the blastocyst and the transformation of the maternal endometrium into a functional decidua. Endometrial stromal fibroblasts undergo the decidualization process in which they differentiate into unique secretory decidual cells that offer a supportive and immune-privileged microenvironment required for embryo implantation and placental development. Decidualizing stromal cells can react to individual embryos in a way that either supports the implantation and subsequent embryonic development or exerts early rejection (Teklenburg et al., 2010; Brosens et al., 2014). Aberrant decidualization processes are observed in patients with recurrent pregnancy loss (RPL), displaying a disordered pro-inflammatory response, decreased induction of decidual marker genes, and abnormal responses to embryonic human chorionic gonadotropin (Teklenburg et al., 2010; Weimar et al., 2012; Salker et al., 2011). In addition to affecting early pregnancy outcomes, defective decidualization is also involved in the maternal etiology of preeclampsia, causing an abnormal placental phenotype (Garrido-Gomez et al., 2017; Garrido-Gomez et al., 2020). The process of decidualization is tightly regulated by hormone signaling pathways (estrogen, E2, and progesterone, P4), as well as by BMP signaling pathways. Our recent studies found that endometrial Smad1 deletion had no significant effect on fertility, Smad5 conditional deletion resulted in subfertility, while double Smad1/5 conditional deletion led to infertility due to implantation and decidualization defects (Monsivais et al., 2021). The uteri of mice with double conditional Smad1/5 deletion also displayed decreased response to P4 during the window of implantation, suggesting synergy between the two pathways. However, the mechanistic genomic actions of SMAD1 and/or SMAD5 in the uterus have not been explored, partly because there are no specific antibodies that distinguish phospho-SMAD1 versus phospho-SMAD5.

In this study, we define how SMAD1/5 instructs the decidualization process using genomic approaches in newly generated transgenic mouse lines. We inspect the potential crosstalk between P4 and BMP signaling pathways mediated by SMAD1/5. Together, our study demonstrates that SMAD1 and SMAD5 exhibit shared and unique genomic binding features and further reveals that SMAD1/5 contributes to the P4 response through transcriptional reprogramming during decidualization.

Results

Generation of mouse models with global HA-tagged SMAD1 and PA-tagged SMAD5 proteins

Activation of BMP signaling pathways has been established as one of the hallmarks of the decidualization process (Gellersen and Brosens, 2014; Magro-Lopez and Muñoz-Fernández, 2021). Canonically, SMAD1/5 are regarded as downstream effectors of BMP2 signaling pathways to regulate decidual-specific gene expressions (Lee et al., 2007; Li et al., 2007). However, our recent findings demonstrated that SMAD1/5 can also affect the sensitivity of the endometrium toward E2 and P4 stimulation (Monsivais et al., 2021). Since we observed phenotypical differences between uterine-specific single SMAD1 and single SMAD5 deletion mice, it is beneficial to delineate the role of SMAD1 and SMAD5 in mediating P4 responses during early pregnancy. We used CRISPR technology to generate genetically engineered knock-in mice with an HA-tagged Smad1 allele (herein called Smad1HA/HA) and PA-tagged Smad5 allele (herein called Smad5PA/PA) as shown in Figure 1A and B. The HA tag and the PA tag were inserted into the N-terminus of the SMAD1 and SMAD5 proteins, respectively. Sanger sequencing was used to confirm genomic insertion (Figure 1A and B, Figure 1—figure supplement 1). To validate the global detection of tagged proteins, we performed immunoprecipitation followed by western blot analysis on different tissues from Smad1HA/HA and Smad5PA/PA mice. We confirmed the HA and PA antibodies can readily detect HA-tagged SMAD1 and PA-tagged SMAD5 proteins at the predicted size (Figure 1C and D). We also demonstrated the molecular size and expression pattern of HA antibody-detected SMAD1 protein was comparable to the SMAD1 antibody-detected SMAD1 protein across different tissue types. Similarly, PA antibody showed comparable signal intensity to the SMAD5 antibody in detecting SMAD5 protein across different tissue types (Figure 1C and D). Thus, we successfully generated viable mouse models with global HA-tagged SMAD1 and PA-tagged SMAD5 proteins.

Figure 1 with 1 supplement see all
Download asset Open asset
Mouse models with global HA-tagged SMAD1 and PA-tagged SMAD5 proteins.

(A, B) Schematic approaches for generating Smad1HA/HA and Smad5PA/PA knock-in mouse lines. Sanger sequencing of the genotyping results is included as validation of knock-in sequence. Black and blue boxes indicate untranslated and coding regions, respectively. (C, D) Immunoblot (IB) analysis of the immunoprecipitation (IP) of HA-tagged SMAD1 and PA-tagged SMAD5 proteins from different tissues of the tagged mouse lines. Wild-type (WT) mice were used as negative controls. Antibodies used for IB and IP are as labeled. Targeted bands of SMAD1 and SMAD5 are indicated by red arrows.

Figure 1—source data 1

Raw uncropped western blot images for Figure 1C and D, without labels.

https://cdn.elifesciences.org/articles/91434/elife-91434-fig1-data1-v1.tiff
Figure 1—source data 2

Uncropped western blot images for Figure 1C, with labels.

https://cdn.elifesciences.org/articles/91434/elife-91434-fig1-data2-v1.tiff
Figure 1—source data 3

Uncropped western blot images for Figure 1D, with labels.

https://cdn.elifesciences.org/articles/91434/elife-91434-fig1-data3-v1.tiff

SMAD1 and SMAD5 exhibit shared and unique genomic binding sites during decidualization

The BMP signaling pathway regulates multiple key events during early pregnancy (Monsivais et al., 2017b), mediated through receptor-regulated SMAD proteins, including SMAD1 and SMAD5. As transducers of the BMP signaling pathway, phosphorylated SMAD1 and SMAD5 form homomeric complexes and then couple with SMAD4 to assemble hetero-oligomeric complexes in the nucleus to execute transcription programs. Our previous studies revealed that conditional ablation of SMAD1 and SMAD5 in the uterus decreased P4 response during the peri-implantation period, suggesting that the transcriptional activities of PR depend on BMP/SMAD1/5 signaling (Monsivais et al., 2021). Furthermore, previous genome-wide PR binding studies show that SMAD1 and SMAD4 binding motifs are enriched in PR binding sites in the uterus (Rubel et al., 2012).

To determine the shared and unique transcriptional regulomes of SMAD1 and SMAD5 contributing to the diverse effects of BMP and P4 signaling pathways during decidualization, we first utilized Cleavage Under Targets & Release Using Nuclease (CUT&RUN) (Skene and Henikoff, 2017) coupled with next-generation sequencing to profile genomic loci bound by SMAD1, SMAD5, and PR from mouse uterine tissues. We performed CUT&RUN on the uterine tissues collected at 4.5 days post coitus (dpc), the time when the fertilized embryo reaches the uterus physically and initiates the decidualization program (Ramathal et al., 2010; Figure 2A). After aligning CUT&RUN reads to the mm10 mouse genome, we called peaks using Sparse Enrichment Analysis for CUT&RUN (SEACR) (Meers et al., 2019). To identify high-confidence peaks, background noise was normalized to IgG and the stringent criteria for peak calling in SEACR were used. After merging common peaks from two biological replicates, we identified 118,778 peaks for SMAD1 and 166,025 total peaks for SMAD5. We visualized the enrichment of SMAD1 and SMAD5 peaks to the overall aligned chromatin regions with clustering for preferential enrichment, as shown in Figure 2B. Peaks in cluster 1 exhibit a shared enrichment for both SMAD1 and SMAD5, whereas clusters 2 and 3 demonstrate preferential enrichment for SMAD5 and SMAD1, respectively. We found that 7.55% of SMAD1 peaks and 9.53% of SMAD5 peaks were located within the ±3 kb of the promoter regions (Figure 2C and D). This corresponded to 10,368 genes that were directly bound by SMAD1 at the promoter regions (±3 kb), whereas 18,270 genes were directly bound by SMAD5 at the promoter regions (±3 kb). Among these, 4933 genes were found in common between SMAD1 (47.5%) and SMAD5 (27.0%), while 2744 and 7427 genes were found to be uniquely bound by SMAD1 and SMAD5, respectively, providing evidence for the shared and unique functions of SMAD1 and SMAD5 at the transcriptional level (Figure 2—figure supplement 1). Hence, interpreting how the binding events correlate to biological activity requires comparisons with gene expression profiling in a tissue-specific manner.

Figure 2 with 1 supplement see all
Download asset Open asset
Genomic profiling of SMAD1 and SMAD5 binding sites during decidualization in vivo.

(A) Diagram outlining experimental approaches for tissue collection, processing, and CUT&RUN. (B) Heatmaps and summary plots showing the enrichment of SMAD1 and SMAD5 binding peaks from one exemplary replicate. Clustering was conducted using k-means algorithm. The colors in the summary plots correspond to clusters labeled in the heatmap below. (C, D) Feature distribution of the annotated peaks for the SMAD1 (C) binding sites and SMAD5 (D) binding sites.

Identification of direct target genes of SMAD1 and SMAD5 during early pregnancy

To pinpoint the direct target genes of SMAD1 and SMAD5, we integrated transcriptomic data from previously published (Monsivais et al., 2021) SMAD1/5 double conditional knockout mice using progesterone receptor cre (SMAD1/5 cKO) (GSE152675) with SMAD1 and SMAD5 genomic data from this article. We cross-compared the differentially expressed genes in the transcriptomic data to the SMAD1 and SMAD5 bound genes, respectively. Among the 805 significantly upregulated genes, we identified 449 genes that were both significantly upregulated upon SMAD1/5 depletion and were directly bound by SMAD1 and SMAD5, whereas 187 of the upregulated genes were bound by SMAD5 only and 30 were bound only by SMAD1 (Figure 3A). Among the 683 significantly downregulated genes, we identified 523 genes that were both significantly downregulated upon SMAD1/5 depletion and were directly bound by SMAD1 and SMAD5, whereas 83 of the downregulated genes were bound by SMAD5 only and 13 were bound by SMAD1 only (Figure 3B, Supplementary file 3b).

Figure 3
Download asset Open asset
SMAD1 and SMAD5 show unique direct target genes during early pregnancy.

(A, B) Venn diagrams showing the shared and unique direct up-target genes (A) and down-target genes (B) of SMAD1, SMAD5. Numbers indicate genes numbers. (C, D) Motif enrichment analysis from the up-targets and down-targets for SMAD1 (C) and SMAD5 (D). (E, F) Dot plot showing Gene Ontology enrichment analysis of shared direct target genes of SMAD1/5 from the up-targets (E) and the down-targets (F), respectively. Dot size represents the gene ratio in the enriched categories compared to background genes, and dot colors reflect p-value.

Next, we utilized Binding and Expression Target Analysis (BETA) algorithm (Wang et al., 2013) to perform motif enrichment analysis of the direct target genes to identify putative co-factors working together with SMAD1 and SMAD5 in controlling gene expression (Figure 3C and D, Supplementary files 1 and 2). ‘Up-targets’ represent genes that were upregulated in the SMAD1/5 cKO mouse uteri and showed either a SMAD1 or a SMAD5 binding site in the genomic profiling data. Similarly, ‘down-targets’ represent genes that were downregulated in the SMAD1/5 cKO mouse uteri and displayed either a SMAD1 or a SMAD5 binding site. Thus, motifs enriched in the ‘up-targets’ indicate potential repressive SMAD1/5 co-factors while motifs enriched in the ‘down-targets’ indicate potential SMAD1/5 co-activators. Among the ‘up-targets’ of SMAD1, MYB Proto-Oncogene (Myb)/MYB Proto-Oncogene Like 1(Mybl1) motif was the most highly enriched with a p-value of 1.85E-02. Myb and Mybl1 transcription factors belong to MYB gene family, which has been well-defined in controlling cell survival, proliferation, and differentiation in cancer (Cicirò and Sala, 2021). In addition, they have also been reported to be E2 induced in human uterine leiomyoma samples (Swartz et al., 2005). Homeobox containing 1 (Hmbox1) and Krüppel-like factor (Klf) family members (Klf4/Klf1/Klf12) were also identified as potential repressive co-factors of SMAD1 with p-values of 2.85E-02 and 3.75E-02, respectively (Figure 3C). Of note, KLF4 has been reported to inhibit the binding activity of estrogen receptor α (ERα) to estrogen response elements in promoter regions (Akaogi et al., 2009). Among the ‘up-targets’ of SMAD5, EBF Transcription Factor 1 (Ebf1) motif was the most enriched with a p-value of 1.57E-02. Interestingly, Ebf1 can directly repress the transcription of Forkhead box protein O1 (Foxo1) (Timblin and Schlissel, 2013). It is also recognized as downstream effector of steroid hormone receptors in the mouse uterus (Pan et al., 2006). Additionally, motifs from transcription factors Zfp128 and Otx1 were also significantly enriched in the upregulated genes bound by SMAD5 (Figure 3D). Taken together, our enrichment analysis provided robust evidence for identifying novel co-factors of SMAD1/5, and such co-regulating mechanisms are in line with the unopposed E2 response observed in the SMAD1/5 cKO mice (Monsivais et al., 2021). Furthermore, odd-skipped-related genes (Osr1 and Osr2) were identified as potential co-activators for SMAD1. Osr2 has been reported to be highly expressed in the human endometrium (Fagerberg et al., 2014), and it was also abundantly detected at the protein level in the human decidual tissues (Ma et al., 2022). Decreased OSR2 level was observed in the patients with recurrent spontaneous abortion and knockdown of OSR2 impairs the decidualization process in the human endometrial stromal cells (EnSCs) (Ma et al., 2022). Moreover, OSR1 has been reported to suppress BMP4 expression, which in turn reduced the Wnt/β-catenin signaling pathways during lung development in Xenopus (Rankin et al., 2012). Apart from Osr family, motifs in the Homeobox genes (HOX) were found to be enriched in the ‘down-targets’ from both SMAD1 and SMAD5 datasets. Specifically, Hoxa11/Hoxd12/Hoxc10 were predicted to be co-activators for SMAD1 while Hoxd10 was indicated to be closely interacting with SMAD5. Indeed, HOX genes are critical for endometrial development in normal and disease conditions and are essential during the establishment of pregnancy (Du and Taylor, 2015; Cakmak and Taylor, 2010; Taylor et al., 1999; He et al., 2018).

With direct target genes of SMAD1 and SMAD5 identified, we then analyzed the Gene Ontology enrichment for the SMAD1/5 shared up-targets and down-targets, respectively. We found that ‘up-target’ genes exhibit enrichment for regulation of cell–cell adhesion, cell junction organization, and desmosome organization (Figure 3E, Supplementary file 3c). Moreover, among the ‘down-target’ genes, we found the enrichment for blood vessel/vasculature development and extracellular matrix organization categories (Figure 3F, Supplementary file 3d). Indeed, during early pregnancy, the stimulation from corpus-luteum-derived P4 enabled the endometrium to be transformed to a receptive state, which allows subsequent embryo attachment and develop through the epithelium into the stromal sections (Gellersen and Brosens, 2014). During this process, apportioned direct cell–cell contacts are ensured by tight and adherent junctions and such interactions are key in facilitating implantation and embryo invasion. In accordance with our findings, desmosomes and adherens junctions were extensively described to decline in the early pregnancy period, which facilitates the invasion of trophoblast through the epithelial layer (Illingworth et al., 2000; Paria et al., 1999; Potter et al., 1996; Grund and Grümmer, 2018). In addition, the stromal compartment of the endometrium also undergoes profound vascular remodeling. Precise regulations of angiogenesis are required to establish an extensive vascular network, which is essential to ensure blood supply and successful embryonic development (Schatz et al., 2016; Evans et al., 2016). Collectively, our findings present evidence that emphasizes the shared roles of SMAD1 and SMAD5 in facilitating endometrial transitions during early pregnancy.

Direct target genes of SMAD1 and SMAD5 maintain the homeostasis of uterine function

To discover novel direct target genes of SMAD1/5, we visualized key genes of interest from the up-targets and down-targets. As shown in Figure 4A, data from RNA-seq represents the decrease of several ‘down-targets’ in the SMAD1/5 cKO mouse uteri, including retinoic acid-related orphan receptor B (Rorb), follistatin (Fst), lymphoid enhancer binding factor 1 (Lef1), and insulin-like growth factor 1 (Igf1). Integrative Genomics Viewer (IGV) track view shows the exemplary SMAD1/5 binding activities near the promoter regions of Rorb and Fst (Figure 4B), demonstrating that these genes are bona fide direct target genes of SMAD1/5. Rorb belongs to the nuclear receptor families in the retinoic acid (RA) signaling pathways (Stehlin-Gaon et al., 2003) and is considered a marker for mesenchymal progenitor cells in the stroma compartment of the endometrium (Spitzer et al., 2012). In murine models, deficient RA signaling through the perturbation of RA receptor in the uterus leads to implantation and decidualization failure (Yin et al., 2021). Fst binds several TGFβ family ligands and thereby inhibits TGFβ family signaling extracellularly (Chang, 2016). Under physiological conditions, Fst is upregulated in the decidua during early pregnancy. Conditional deletion of Fst in the mouse uterus results in severe subfertility with a phenotype of non-receptive epithelium and poorly differentiated stroma (Fullerton et al., 2017). Notably, RA signaling deficiency also decreases Fst levels in the uterus and systematic administration of FST can fully rescue the deficient-decidualization phenotype but not the non-receptive phenotype observed in the RA receptor mutant mice (Yin et al., 2021). Our results suggest a direct relationship between BMP and RA signaling pathway, accomplished by SMAD1/5 at the transcriptional level, likely establishing a positive signaling feedback loop. Apart from being a crucial transcriptional activator, SMAD1/5 also plays a role in repressing key gene expression pathways. Shown in Figure 4C, upon the deletion of SMAD1/5 in the mouse uteri, several E2-responsive genes were significantly upregulated, including fibroblast growth factor receptor 2 (Fgfr2), matrix metallopeptidase 7 (Mmp7), and Wnt family member 7B (Wnt7b). In addition, Inhbb, a downstream target of Fst (Fullerton et al., 2017), is also a target gene of SMAD1/5 that resulted in transcriptional repression. SMAD1/5 binding on the Fgfr2 and Mmp7 genes are exemplified in an IGV track view in Figure 4D. Fgfr2 and its ligands regulate epithelial cell proliferation and differentiation. Components of the fibroblast growth factor (Fgf) signaling pathway are cyclically expressed in the uterus and act as paracrine and/or autocrine mediators of epithelial–stromal interactions (Li et al., 2011; Filant et al., 2014). During early pregnancy in mice, P4 inhibits expression of Fgf2 in the stromal cells, which is critical to counteract the E2-driven epithelial proliferation (Li et al., 2011). Similar observations are reported in gilts, where the expression of Fgfr2 decreased alongside with increased parity of the sows (Lim et al., 2017). It is also noteworthy that loss of function of Fgfr2 in the mouse uterus leads to luminal epithelial stratification and peri-implantation pregnancy loss (Filant et al., 2014). Moreover, Mmp7 and Wnt7b are upregulated upon E2 stimulation and participate in the re-epithelialization of the endometrium and implantation process, respectively (Russo et al., 2009; Tenvergert et al., 1992; Hayashi et al., 2009). In accordance with the phenotype of hyperproliferative endometrial epithelium during early pregnancy, observed in SMAD1/5 cKO mice, we demonstrated that the suppression of key E2-responsive genes, such as Fgfr2 and Mmp7, by SMAD1/5 maintains the precise balance between E2 and P4.

Figure 4 with 1 supplement see all
Download asset Open asset
Direct target genes of SMAD1/5 mediate uterine homeostasis.

(A) Bar graph of normalized fragments per kilobase of transcript per million mapped reads (FPKM) of downregulated transcripts in the control and SMAD1/5 conditional knockout (cKO) groups as indicated by the label. Histograms represent average ± SEM of experiments uteri from control mice (N = 3) and SMAD1/5 cKO mice (N = 4). Analyzed by an unpaired t-test. (B) Integrative Genomics Viewer (IGV) track view of SMAD1, SMAD5 binding activities. Gene loci are as indicated in the figure, genomic coordinates are annotated in mm10. (C) Bar graph of FPKM of upregulated transcripts in the control and SMAD1/5 cKO groups as indicated by the label. (D) IGV track view of SMAD1, SMAD5 binding activities. Gene loci are as indicated in the figure, genomic coordinates are annotated in mm10. (E) Dot plot showing the gene expression pattern of the key SMAD1/5 direct target genes in different cell types from published human endometrium single-cell RNA-seq dataset.

To explore the major cell types regulated by SMAD1/5, first, we used CIBERSORTx (Newman et al., 2019) to analyze and depict changes in the cell populations upon SMAD1/5 depletion in the mouse uterus during early pregnancy. By imputing the bulk uterine gene expression profiles to previously published mouse uterine single-cell datasets (Yang et al., 2023) using CIBERSORTx (Newman et al., 2019), we were able to compare changes across both samples and cell types upon the SMAD1/5 perturbation in the mouse uterus. We highlight the proportional increase in the epithelial cells, as well as the decrease in the decidual stromal cells and smooth muscle cells in mice lacking uterine SMAD1/5 during the peri-implantation phase (Figure 4—figure supplement 1). Such cell populational changes are in line with the phenotypical observations of decidualization failure and excessive proliferation in the epithelial compartment. In addition, to explore the expression patterns of SMAD1/5 direct targets in human, we profiled the expression levels of the key ‘up-targets’ and ‘down-targets’ in the different cell types of the human endometrium. Using previously published single-cell RNA-seq data of human endometrium (Garcia-Alonso et al., 2021), we visualized the expression patterns of suppressive targets and activating targets of SMAD1/5 (Figure 4E). Apart from the major epithelial and stromal compartments, SMAD1/5 target genes are also widely expressed in the immune cell populations. Such observations reinforced the importance of the BMP signaling pathways in establishing an immune-privileged environment at the maternal–fetal interface (PrabhuDas et al., 2015).

SMAD1 and SMAD5 co-regulate PR target genes

SMAD1/5 cKO mice were infertile due to endometrial defects and displayed decreased P4 response during the peri-implantation period (Monsivais et al., 2021). Hence, we hypothesized that SMAD1 and SMAD5 act as co-regulators of P4-responsive genes during the window of implantation and are required for endometrial receptivity and decidualization. By determining the genomic co-occupancy of SMAD1, SMAD5, and PR, we aimed to clarify the transcriptional interplay between the BMP and P4 signaling pathways. To this end, we performed additional PR CUT&RUN experiments on the uteri of mice collected at 4.5 dpc and identified 134,737 peaks showing PR binding activities (Figure 5A). Based on the k-means clustering results of the peaks, we demonstrated clusters with shared occupancy between SMAD1/5 and PR (cluster 1), preferential deposition in the SMAD1 (cluster 2), SMAD5 (cluster 4), and PR (clusters 3 and 5), respectively. Interestingly, between clusters 3 and 5, although the primary enrichment is for PR, overall the signal intensities for SMAD5 are higher in cluster 5. Together with previous analysis on genes uniquely or commonly bound by SMAD1/5 (Figure 2—figure supplement 1), we speculate such observation can be attributed to a subset of the genes that are potentially co-regulated by SMAD5 and PR. From the gene perspective, we identified 7393 genes that were directly bound by PR at the promoter regions (±3 kb), among which 2596 genes were also concurrently bound by both SMAD1 and SMAD5 at the promoter regions (±3 kb) (Figure 5—figure supplement 1A).

Figure 5 with 1 supplement see all
Download asset Open asset
SMAD1 and SMAD5 co-regulate progesterone receptor (PR) target genes.

(A) Heatmaps and summary plots showing the enrichment comparison between SMAD1, SMAD5, and PR binding peaks from one exemplary replicate. Clustering was conducted using k-means algorithm. The colors in the summary plots correspond to clusters labeled in the heatmap below. (B) Dot plot showing KEGG pathway enrichment analysis for shared genes bound by SMAD1, SMAD5, and PR. (C) Integrative Genomics Viewer (IGV) track view of SMAD1, SMAD5, and PR binding activities. Gene loci are as indicated in the figure, genomic coordinates are annotated in mm10. (D) Table of motif analysis results for shared peaks between SMAD1, SMAD5, and PR, with p-value and motif annotation specified for each motif.

Next, we performed KEGG pathway enrichment for the genes co-bound by SMAD1, SMAD5, and PR. As expected, pathways critical for decidualization such as relaxin signaling pathways and WNT signaling cascade were identified in the enrichment results (Figure 5B, Supplementary file 3e). We visualized exemplary genes co-regulated by SMAD1, SMAD5, and PR and presented in the normalized IGV track view (Figure 5C). We demonstrated SMAD1, SMAD5, and PR showed co-occupancy at the loci of the SRY-box transcription factor 17 (Sox17), inhibitor of DNA binding 2 (Id2), forkhead box protein O1 (Foxo1), insulin-like growth factor 1 (Igf1), transforming growth factor beta receptor 2 (Tgfbr2), and RUNX family transcription factor 1 (Runx1) (Figure 5C). Sox17 has been reported as one of the direct target genes of PR (Rubel et al., 2012) and is essential for uterine functions during implantation and early pregnancy (Guimarães-Young et al., 2016; Hirate et al., 2016). More recent studies also showed the importance of Sox17 in regulating uterine epithelial–stromal crosstalk and its indispensable role in female fertility (Wang et al., 2018). We provided evidence that Sox17 is also directly regulated by SMAD1/5 complexes. Our results indicated that Id2, considered as canonical direct transcriptional targets of BMP-SMAD signaling (Hollnagel et al., 1999; Miyazono and Miyazawa, 2002), is also regulated by PR. We also confirmed that known P4-responsive genes such as Tgfbr2 (Holloran et al., 2020) and Runx1 (Dinh et al., 2023), as well as decidual markers such as Foxo1 (Vasquez et al., 2018) and Igf1 (Shi et al., 2022), were co-regulated by SMAD1, SMAD5, and PR (Figure 5C).

To identify additional transcription factors that are associated with the regulatory interplay between SMAD1/5 and PR during decidualization, we performed unbiased motif analysis on the shared CUT&RUN peaks between SMAD1/5 and PR. We reported the top 10 transcription factors harboring the enriched motifs, including NANOG, Homeobox A protein family (HOXA11 and HOXA9), NK6 homeobox 1(NKX6.1), TGFB-induced factor homeobox 2 (TGIF2), FOS, RUNX family transcription factor 2 (RUNX2), androgen receptor (AR), SOX17, and lymphoid enhancer-binding factor 1 (LEF1) (Figure 5D, Supplementary file 3f). Many of these putative interactors have been reported to interact with the SMAD proteins in other biological processes. For example, NANOG interacts with SMAD1 during mesoderm differentiation (Suzuki et al., 2006). HOXA9 forms heterodimers with SMAD4, leading to BMP-driven initiation of transcription from the mouse Opn promoter in vitro (Shi et al., 2001; Shi et al., 1999). Transcription factor AP-1 family (FOS) and RUNX2, as well as β-catenin/Lef1 complex, increase the effectiveness and specificity of DNA binding activities of SMAD1/5 in response to BMP ligand stimuli (Feng and Derynck, 2005; Massagué et al., 2005; Derynck and Budi, 2019). To further evaluate the key roles of SMAD1/5 as major uterine transcription regulators, we cross-compared the genomic binding sites of SMAD1/5 with known key transcription factors, namely aforementioned SOX17 (Figure 5—figure supplement 1B, Supplementary file 3g), as well as NR2F2 (Figure 5—figure supplement 1C, Supplementary file 3h), an essential regulator of hormonal response (Lee et al., 2010), using our CUT&RUN data sets and published mouse uterine SOX17 and NR2F2 ChIP-seq data sets (GSE118328, GSE232583). Among the annotated genes, 5402 genes are shared between SMAD1/5 and SOX17, and 1922 genes are shared between SMAD1/5 and NR2F2. Such observations indicate a potential co-regulatory mechanism between SMAD1/5 and other key uterine transcription factors in maintaining appropriate uterine functions. Overall, our analyses demonstrate that the transcriptional activity of SMAD1, SMAD5, and PR coordinates the expression of key genes required for endometrial receptivity and decidualization.

Decidualization of human endometrial stromal cells requires SMAD1/SMAD5

We next sought to functionally characterize the role of SMAD1/5 during decidualization in human EnSCs. To do so, we examined the effect of SMAD1/5 perturbations on the decidualization of primary human EnSCs. EnSCs were transfected with short interfering RNAs (siRNAs) targeting each gene (SMAD1 and SMAD5) and subjected to in vitro decidualization by treatment with E2-cAMP-and MPA (EPC) for 4.5 d (Figure 6A, Figure 6—figure supplement 1). We hypothesized that the combined SMAD1/5 knockdown would impair the decidualization process significantly compared to cells treated with non-targeting siRNAs. Our results demonstrated that SMAD1/5 knockdown affected decidualization and led to significantly decreased expression of the canonical decidual markers, PRL and IGFBP1 in EnSCs (Figure 6B). The PR co-regulator, FOXO1 (Vasquez et al., 2015), also exhibited a significant decreasing trend in the siSMAD1/5 group. We also examined the expression level of the RA pathway regulator gene, RORB, and of the SMAD4-PR target gene, KLF15 (Monsivais et al., 2016), following SMAD1/5 perturbation. We observed a significant decrease in both RORB and KLF15 expression upon SMAD1/5 knockdown during in vitro decidualization treatment (Figure 6C). Taken together, our findings indicate that SMAD1/5 can modulate PR activity during decidualization and that this transcriptional cooperation is required for the in vitro decidualization of primary human EnSCs.

Figure 6 with 1 supplement see all
Download asset Open asset
SMAD1 and SMAD5 are required for progesterone receptor (PR) responses during decidualization of human endometrial stromal cells (EnSCs).

(A) Schematic approach and timeline outlining in vitro decidualization for EnSCs. (B, C) RT-qPCR results showing mRNA levels of PRL, IGFBP1, FOXO1, RORB, and KLF15 after SMAD1/5 perturbation using siRNAs. Data are normalized to siCTL-Veh for visualization. Bar graphs represent average ± SEM of experiments on cells from three different individuals with technical triplicates. Analyzed by a one-way ANOVA with post hoc Tukey test.

Discussion

SMAD proteins are canonical transcription factors that are activated in response to TGFβ family signaling and mediate the biological effects of these pathophysiologically critical ligands (Massagué et al., 2005). While SMAD2 and SMAD3 are downstream of TGFβs, activins, and multiple other family ligands, SMAD1 and SMAD5 preferentially transduce BMP signaling pathways and are regarded as pivotal activators for many physiological processes, including bone development, cardiac conduction system development, and embryonic pattern specification (Wu et al., 2016; van Weerd and Christoffels, 2016; Whitman, 1998). Importantly, SMAD1 and SMAD5 are implicated in diverse female reproductive physiology and pathophysiology processes (Monsivais et al., 2017b; Monsivais et al., 2021; Middlebrook et al., 2009; Pangas et al., 2008; Rodriguez et al., 2016).

Due to high structural similarity, SMAD1/5 have been suggested to be redundant from the studies in ovarian biology and chondrogenesis (Pangas et al., 2008; Retting et al., 2009). However, other studies clearly demonstrated that SMAD1/5 have different roles in governing hematopoiesis and uterine functions (Monsivais et al., 2021; McReynolds et al., 2007). The DNA binding activities of SMAD1 and SMAD5 have not been readily distinguished from each other due to anti-phospho antibody limitations. To robustly define the roles of SMAD1/5 in regulating transcriptional programs in vivo, we produced two genetically engineered mouse models with global knock-in of an HA tag and a PA tag in the Smad1 and Smad5 loci, respectively. We showed that SMAD1 and SMAD5 not only have shared transcriptional activities but also have unique roles in uterine physiology. In agreement with previous studies showing that SMAD1/5 function is partially redundant (Pangas et al., 2008; Retting et al., 2009), we confirmed that SMAD1/5 share a total of 972 direct target genes in the uterus. Furthermore, we demonstrated that 43 genes were uniquely regulated by SMAD1 whereas 270 genes are specifically regulated by SMAD5 only. Our motif analysis also revealed distinct potential co-factors between SMAD1 and SMAD5, providing evidence at the molecular level to mechanistically delineating the distinct roles of SMAD1 and SMAD5 in directing cellular processes in the uterus.

Apart from directly regulating target gene expression, our data demonstrate that SMAD1/5 present as dense genomic occupancies. To date, only a limited amount of transcription factors have been investigated using the CUT&RUN-seq technique from the tissue samples due to antibody compatibility issue. We recognize that the binding sites and gene number identified here are quite high; however, the high density of binding events was also observed in the ENCODE (Consortium E. P, 2012) chromatin immunoprecipitation followed by sequencing (ChIP-seq) data for SMAD1 and SMAD5 in the human K562 cells, detecting an average of 63,563 peaks for SMAD1 and 109,682 peaks for SMAD5. (Data accessed through GSE95876 and GSE127365 from Gene Expression Omnibus.) Multiple aspects can contribute to the observation of dense SMAD1/5 genome occupancies. First, transcription factors (TFs) tend to dwell or ‘search and bind’ throughout the genome (Chen et al., 2014). Such events may not yield actual biological effects but rather are due to differences in motif binding affinities (Swinstead et al., 2016). Second, apart from robust binding activities, TFs may not initiate transcription programs owing to the lack of co-factors or favorable conditions to exert their functions (Chen et al., 2020). Additionally, TF binding sites and target genes are unlikely to have a one-to-one relationship. TFs could be positioned from the proximal promoter regions to hundreds of kilobases afar to modulate gene expression. In the meantime, the same binding site could regulate multiple genes by interacting with different promoters in different subpopulations of cells. Lastly, TFs usually direct target gene expression in a cell-type-specific manner (Arvey et al., 2012). Our genomic profiling samples were collected from whole uterus at the time of 4.5 dpc, containing a great range of cell populations, including but not limited to the epithelium (luminal and glandular), stroma (progenitors and differentiated cells), myometrium, endothelium, and immune cell populations. The data is therefore expected to depict the dynamic and complex activities of SMAD1/5 in the entire uterus. Together, the stringent filtering and normalization criteria, comparable peak number to the published dataset, and IGV track view visualization collectively validate our CUT&RUN experiments and uncover the enriched regions as robust SMAD1/5 binding events. Our studies also examined the role of SMAD1/5 in mediating progesterone responses at the genomic and transcription levels. Similarly, our analysis was based on datasets generated from the whole mouse uterus, which contains multiple compartments of the uterine structures, including but not limited to epithelium and stroma. Published studies have shown that nuclear SMAD1/5 localize to the stroma and epithelium during the decidualization process at 4.5 dpc, during the window of implantation (Monsivais et al., 2021). Conditional deletion of SMAD1/5 exclusively in the uterine epithelium using lactoferrin-icre (Ltf-icre) results in severe subfertility due to impaired implantation and decidual development (Tang et al., 2022). Conditional deletion of SMAD1/5/4 exclusively in the cells from mesenchymal lineage (including uterine stroma) using anti-Mullerian hormone type 2 receptor cre (Amhr2-cre) results in infertility with defective decidualization (Pangas et al., 2008; Rodriguez et al., 2016). Given the essential roles of SMAD1/5 in both stroma and epithelium identified by previous studies, we believe that the transcriptional co-regulatory roles of SMAD1/5 and PR reported here using the whole uterus validate a relationship between SMAD1/5 and PR in both the stromal and epithelial compartments. However, it does not rule out potential co-regulatory roles of SMAD1/5 and PR in the myometrium, immune cells, and/or endothelium, given that whole uterus was used. The specific transcriptional evaluations of SMAD1/5 in the stroma versus the epithelium would require future validations using single-cell sequencing and/or spatial transcriptomic analysis.

Although our studies herein confirm that SMAD1 and SMAD5 proteins have distinct transcriptional regulatory activities, our previous studies demonstrated that while SMAD5 can functionally replace SMAD1, SMAD1 cannot replace SMAD5 in the uterus (Monsivais et al., 2021). How this epistatic relationship is established in a tissue-specific manner still needs to be determined by further biochemical investigations. In addition, further studies are needed to uncover whether SMAD1 and SMAD5 response differently upon ligand stimulation in the uterus, and if so, how the preference is achieved. Our study provides versatile in vivo genetic tools for these questions and can advance the toolbox for the field studying BMP signaling pathways. Because our mouse models are global knock-in mice, they will not only serve as a powerful tool for studying BMP signaling pathways in the reproductive system but will also promote the study of BMP signaling in other organs and tissues.

BMP signaling pathways are involved in a plethora of cellular processes and appropriate functioning of the BMP pathway depends on the precise crosstalk with other signaling pathways. Coordinated communication with other pathways can yield synergistic effects and lead to a complex regulatory network of biological processes. To be specific, SMAD1/5 mediates the crosstalk with the WNT/β-catenin pathway. WNT signaling inhibits glycogen synthase kinase 3β (GSK3β) activity and prevents SMAD1 from degradation, which governs the embryonic pattern formation (Fuentealba et al., 2007). Also, SMAD1/5 can physically interact with T-cell factor (TCF) or lymphoid enhancer factor (LEF) transcription factors to form transcriptional complexes to activate the transcription of many WNT-and BMP-responsive genes (Labbé et al., 2000). In addition, SMAD1 and SMAD5 can directly associate with Notch intracellular domain and enhance known Notch target gene expression by binding to their regulatory DNA sequences (Zavadil et al., 2004). Intriguingly, in prostate cells, SMAD1 physically interacts with the androgen receptor (AR) and halts the androgen-stimulated prostate cell growth (Qiu et al., 2007). Moreover, we provide first-hand evidence showing that BMP signaling pathways converge with RA signaling pathways through the regulation of RORB by SMAD1/5. Further studies will grant a more detailed mechanism of the positive feedback loop between BMP and RA signaling.

Our previous studies suggest that the mouse endometrium presents decreased P4 responsiveness following the conditional deletion of SMAD1/5 in the uterus (Monsivais et al., 2021). In accordance with the phenotypical observation, we offer compelling support in our current study that SMAD1/5 work collectively with PR to regulate their target genes and that SMAD1/5 mediate the crosstalk between BMP and P4 signaling pathways during decidualization, a key process to ensure a successful pregnancy, and ultimately direct the biological transformations of the uterus during early pregnancy. We provide genomic evidence that SMAD1/5 are co-bound at around 35% of PR target genes in the mouse uterus during decidualization. Correspondingly, in a previously published study where they performed PR ChIP-seq in the mouse uterus after P4 stimulation, the SMAD1 motif was the fifth most significantly enriched sequence motifs identified (Rubel et al., 2012). In parallel, we also identified nuclear receptor motifs (i.e., PR sequence motifs) enriched in the SMAD1/5 binding sites (Figure 5—figure supplement 1D and E). From pathway enrichment analysis, we demonstrate that genes with SMAD1/5 and PR bound at the promoter regions are enriched for key pathways in directing the decidualization process, such as WNT and relaxin signaling pathways. Future studies can benefit from analyzing binding events beyond the promoter regions. Profiling the PR genome occupancy in the SMAD1/5-deficient mice would provide an interesting perspective to reevaluate the major regulatory roles of SMAD1/5 in mediating uterine transcriptomes. In this study, we determined the overlapped transcriptional control between SMAD1/5 and PR at the gene level, and functionally validated the regulatory effect at the transcript level in a human stromal cell decidualization model. While we observe a subset of peak representations that do not overlap at the base pair level in the promoter regions, future functional screenings at the promoter level, such as luciferase reporter assays to assess transcriptional co-activation by SMAD1/5 and PR, will advance this study.

SMADs are known to recruit co-repressors (i.e., Ski; Luo et al., 1999) or co-activators (i.e., p300; Pouponnot et al., 1998) to inhibit or activate target gene transcription, less is known about their cell-specific co-factors that confer the precise spatial-temporal control over binding activities to target genes. Our study highlights the potential co-factors by integrating both genomic and transcriptomic data to delineate signaling crosstalks that are responsible for maintaining tissue homeostasis, especially in the female reproductive tract.

Since mice only undergo decidualization upon embryo implantation whilst human stromal cells undergo cyclic decidualization in each menstrual cycle in response to rising levels of progesterone (Ramathal et al., 2010), asynchronous gene responses may occur in comparison between mouse models and human cells. However, cellular transformation during decidualization is conserved between mice and humans (Gellersen and Brosens, 2014), which makes findings in the mouse models a valuable and transferable resource to be evaluated in human tissues. Accordingly, our functional validation studies were performed using human EnSCs induced to decidualize in vitro for 4 d, which models the early phases of decidualization. Additional transcriptomic studies of the SMAD1/5 perturbations in human EnSCs will be of great resource in understanding the entire SMAD1/5 regulomes in humans.

In summary, our findings and those of others indicate that SMAD1 and SMAD5 not only are signal transducers for BMP signaling pathways, but also engage extensively in the crosstalk with PR signaling pathways. While P4 responses are critical for early pregnancy establishment, abnormal P4 responses are implicated in diseases such as endometriosis and endometrial cancers (Brosens and Gellersen, 2006; Yilmaz and Bulun, 2019; Janzen et al., 2013; MacLean and Hayashi, 2022). Hence, our results show that BMP and P4 signaling pathways synergize within the endometrium; these key pathways can shed light on the endometrial contribution to conditions that impact reproductive health in women, including early pregnancy loss, endometriosis, and endometrial cancer. Furthermore, we anticipate that the SMAD1/5 knock-in-tagged transgenic mouse models developed herein will be useful for studying BMP/SMAD1/5 signaling pathways in other reproductive and non-reproductive tract tissues in the body.

Materials and methods

Key resources table
Reagent type (species) or resourceDesignationSource or referenceIdentifiersAdditional information
Strain, strain background (Mus musculus)C57BL/6J × 129S5/SvEvBrdThis paperC57BL/6J × 129S5/SvEvBrdCan be obtained by contacting the corresponding authors
Transfected construct (Homo sapiens)siCTL, siSMAD1, siSMAD5DharmaconCat# D-001810-10, L-012723-00-0005, L-015791-00-0005
Biological sample (M. musculus)Primary uterine tissuesThis paperFreshly isolated from 4.5 dpc mice. Can be obtained by contacting the corresponding authors
AntibodyAnti-HA (rabbit polyclonal)EpiCypherCat# 13-2010, RRID:AB_3094663CUT&RUN (1:50)
AntibodyAnti-PA (rat monoclonal)FUJIFILM Wako Pure Chemical CorporationCat# NZ-1, RRID:AB_3094664CUT&RUN (1:50)
IP (10 ug/assay)
WB (1:1000)
AntibodyAnti-HA (rabbit monoclonal)Cell Signaling TechnologyCat# 3724, RRID:AB_1549585IP (1:50)
WB (1:1000)
AntibodyAnti-SMAD1 (rabbit monoclonal)Innovative ResearchCat# 385400, RRID:AB_431530WB (1:1000)
AntibodyAnti-SMAD5 (rabbit polyclonal)ProteinTechCat# 12167-1-AP, RRID:AB_2286502WB (1:1000)
Sequence-based reagentS1-F1MilliporeSigmaPCR primersCAAACCGCAGACCAAGAAGC
Sequence-based reagentS1-R1MilliporeSigmaPCR primersCTTCTCCAGCTCTTCCATGGC
Sequence-based reagentS5-F1MilliporeSigmaPCR primersTGCTTAAGACCTGCATGTGACT
Sequence-based reagentS5-R1MilliporeSigmaPCR primersCATCCACTGCCTTTTCTGCC
Sequence-based reagentGAPDH-FMilliporeSigmaRT-qPCR primersACAACTTTGGTATCGTGGAAGG
Sequence-based reagentGAPDH-RMilliporeSigmaRT-qPCR primersGCCATCACGCCACAGTTTC
Sequence-based reagentACTB-FMilliporeSigmaRT-qPCR primersCTGGAACGGTGAAGGTGACA
Sequence-based reagentACTB-RMilliporeSigmaRT-qPCR primersAAGGGACTTCCTGTAACAATGCA
Sequence-based reagentRPL13A-FMilliporeSigmaRT-qPCR primersCCTGGAGGAGAAGAGGAAAGAGA
Sequence-based reagentRPL13A-RMilliporeSigmaRT-qPCR primersTTGAGGACCTCTGTGTATTTGTCAA
Sequence-based reagentRORB-FMilliporeSigmaRT-qPCR primersTGTGCCATCCAGATCACTCACG
Sequence-based reagentRORB-RMilliporeSigmaRT-qPCR primersGGTTGAAGGCACGGCACATTCT
Sequence-based reagentSMAD5-FMilliporeSigmaRT-qPCR primersCTCGCGAAAAGGAAGCTGTTG
Sequence-based reagentSMAD5-RMilliporeSigmaRT-qPCR primersGGGTCAAGTCAGAGGCAGATT
Sequence-based reagentSMAD1-FMilliporeSigmaRT-qPCR primersATGGTGACACAGTTACTCGGT
Sequence-based reagentSMAD1-RMilliporeSigmaRT-qPCR primersAGAGACTTCTTGGGTGGAAACA
Sequence-based reagentKLF15-FMilliporeSigmaRT-qPCR primersGTGAGAAGCCCTTCGCCTGCA
Sequence-based reagentKLF15-RMilliporeSigmaRT-qPCR primersACAGGACACTGGTACGGCTTCA
Commercial assay or kitPrimePCR SYBR Green Assay: FOXO1, HumanBio-RadqHsaCED0004488
Commercial assay or kitPrimePCR SYBR Green Assay: IGFBP1, HumanBio-RadqHsaCID0014281
Commercial assay or kitPrimePCR SYBR Green Assay: PRL, HumanBio-RadqHsaCID0015557

Generation of knock-in mouse lines

Request a detailed protocol

Smad5PA/PA knock-in (KI) mice were generated using a similar approach as previously described (Shimada et al., 2021). Briefly, single-guide RNA (sg-RNA) was designed to target the regions close to the start codon (Figure 1A and B) and the sgRNA sequence was inserted into the pX459 V2.0 plasmid (#62988, Addgene). The reference plasmids containing PA tag sequence were constructed in pBluescript II SK (+) vector (Agilent, Palo Alto, CA). Then, 1 μg of guide RNA inserted vector and 1.0 μg of reference plasmid were co-transfected into EGRG01 embryonic stem (ES) cells. Out of 48 ES clones, 12 had the expected knock-in allele. ES cell clones that possessed the proper KI allele were injected into ICR embryos and chimeric blastocysts were transferred into pseudopregnant females. Chimeric male mice were mated with B6D2F1 female mice to obtain the PA-tagged SMAD5 KI heterozygous mice. Homozygous Smad5PA/PA mice were maintained in the C57BL/6J × 129S5/SvEvBrd mixed genetic background. To generate Smad1HA/HA mice, Cas9 protein (Thermo Fisher, A36497), sg-RNA, and a repair oligo of homology-directed repair (HDR) containing HA-tag and linker sequences were electroporated into zygotes harvested from in vitro fertilization using B6D2F1 male and female mice. An ECM830 electroporation system (BTX, Holliston, MA) was used for electroporation. Subsequently, embryos were cultured overnight to the two-cell stage and then transferred to the oviducts of pseudopregnant CD-1 mice (Center for Comparative Medicine, Baylor College of Medicine). Pups were further screened for successful heterozygous or homozygous knock-in alleles by PCR using primers spanning across the HA tag. Sequences of sgRNA, the single-stranded repair oligo for HDR, and primer used for genotype are listed in Supplementary file 3a.

Animal ethics compliance and tissue collection

Request a detailed protocol

All mice were housed under standard conditions of a 12 hr light/dark cycle in a vivarium with controlled ambient temperature (70°F ± 2°F and 20–70% relative humidity). All mouse handling and experimental procedures were performed under AN-716 protocol approved by the Institutional Animal Care and Use Committee of Baylor College of Medicine. All experiments were performed with female mice aged between 7 and 12 wk with a C57BL/6J × 129S5/SvEvBrd mixed genetic background. All mice were euthanized using isoflurane induction followed by cervical dislocation, and tissues were snap-frozen in liquid nitrogen.

CUT&RUN approach

Request a detailed protocol

Nuclei from uterine tissues were purified following a previously published protocol (Fang et al., 2014). The experiments were performed using pooled biological replicates from two mice that were processed as technical replicates throughout the CUT&RUN procedure and analysis. In short, uteri were harvested from pregnant mice at 4.5 dpc and washed with cold swelling buffer (10 mM Tris–HCl pH 7.5, 2 mM MgCl2, 3 mM CaCl2, 1X Protease Inhibitor Cocktail [PIC, Roche, 11836170001]) immediately after collection. Then tissue was cut into small pieces (~2–3 mm) using scissors, while submerged in cold swelling buffer. Nuclear extract was prepared by dounce homogenization in cold swelling buffer (using a size 7 dounce) and filtered using the cell strainer (100 μm, BD Biosciences). Lysate was centrifuged at 400 × g for 10 min, then resuspended in lysis buffer (swelling buffer with 10% glycerol and 1% CA-630, 1× PIC) using end-cut or wide-bore tips and incubated on ice for 5 min. Nuclei were washed twice with lysis buffer and resuspended in lysis buffer. Next, CUT&RUN procedure largely follows a previous protocol (Skene and Henikoff, 2017). Briefly, around 500,000 nuclei were used per reaction. 10 μl of concanavalin-coated beads (Bangs Labs, BP531) were washed twice in Bead Activation Buffer (20 mM HEPES, pH 7.9, 10 mM KCl, 1 mM CaCl2, 1 mM MnCl2) for each reaction. Then, beads were added to nuclei resuspension and incubated for 10 min at room temperature. After incubation, bead-nuclei complexes were resuspended in 100 μl Antibody Buffer (20 mM HEPES, pH 7.5, 150 mM NaCl, 0.5 mM spermidine, 1× PIC, 0.01% digitonin, and 2 mM EDTA) per reaction. Then, 1 μg of IgG antibody (Sigma, I5006), HA antibody (EpiCypher, 13-2010), PA antibody (Fuji Film, NZ-1), and PR antibody (Cell Signaling, D8Q2J) were added to each group respectively. After overnight incubation at 4°C, bead-nuclei complexes were washed twice with 200 μl cold Dig-Wash buffer (20 mM HEPES pH = 7.5, 150 mM NaCl, 0.5 mM spermidine, 1× PIC, 0.01% digitonin) and resuspended in 50 μl cold Dig-Wash buffer with 1 μl pAG-MNase (EpiCypher, 15-1016) per reaction. After incubation at room temperature for 10 min, bead-nuclei complexes were washed twice with 200 μl cold Dig-Wash buffer and resuspended in 50 μl cold Dig-Wash buffer, then 1 μl 100 mM CaCl2 was added to each reaction. The mixture was incubated at 4°C for 2 hr and the reaction was stopped by adding 50 μl Stop Buffer (340 mM NaCl, 20 mM EDTA, 4 mM EGTA, 0.05% Digitonin, 100 ug/ml RNase A, 50 mg/ml glycogen, 0.5 ng Escherichia coli DNA Spike-in [EpiCypher, 18-1401]) and incubate at 37°C for 10 min. The supernatant was collected and subjected to DNA purification with phenol-chloroform and ethanol precipitation. Sequencing libraries were prepared using NEBNext Ultra II DNA Library Prep Kit (New England BioLabs, E7645) following the manufacturer’s protocol. Paired-end 150 bp sequencing was performed on a NEXTSeq550 (Illumina) platform.

Bioinformatic analysis for CUT&RUN data and reanalysis of published single-cell RNA-seq data

Request a detailed protocol

For CUT&Run data, raw data were de-multiplexed by bcl2fastq v2.20 with fastqc for quality control. Clean reads were mapped to reference genome mm10 by Bowtie2, with parameters of --end-to-end --very-sensitive --no-mixed --no-discordant --phred33 -I 10 -X 700. For spike-in mapping, reads were mapped to E. coli genome U00096.3. Duplicated reads were removed, and only uniquely mapped reads were kept. Spike-in normalization was achieved through multiply primary genome coverage by scale factor (100,000/fragments mapped to E. coli genome). CUT&RUN peaks were called by SECAR (Meers et al., 2019) with the parameters of -norm -stringent -output. Track visualization was done by bedGraphToBigWig (Kent et al., 2010), bigwig files were imported to IGV for visualization. For peak annotation, common peaks were identified with 'mergePeaks' function in HOMER v4.11 (Heinz et al., 2010) and then genomic annotation was added by ChIPseeker (Yu et al., 2015). Motif analysis was conducted through HOMER v4.11 with parameter set as findMotifsGenome.pl mm10 -size 200 -mask (Heinz et al., 2010). Peak heatmaps were plotted using deepTools 2.4.2 with clustering options set to k-means (Ramírez et al., 2016). For imputing the cell fractions using published mouse uterine bulk and single-cell RNA-seq data, single-cell RNA-seq with cell type reference from 5.5 dpc mouse uterus was derived from GSE226417, bulk RNA-seq of the 3.5 dpc mouse uterus was derived from GSE152675. Signature matrix and cell fraction profiles were conducted through CIBERSORTx (Newman et al., 2019). Briefly, reference gene expression signature matrix was generated by ‘Create Signature Matrix’ module with default settings. Next, cell fractions were calculated using ‘Impute Cell fractions’ module in the absolute mode, which scales each annotated cellular fractions to an absolute value that reflects its absolute proportion in the bulk sample. For human single-cell RNA-seq data, raw data was obtained from EMBL-EBI under accession no. E-MTAB-10287. Cells with low coverage (less than 500 genes detected) were filtered, then gene counts were normalized for each cell by converting counts to quantiles and obtaining the corresponding values from a normal distribution. Then normalized cell vectors are concatenated along the gene panel. Plot visualization was conducted through CELLXGENE platform (Abdulla et al., 2023).

Western blot analysis of immunoprecipitation (IP-WB)

Request a detailed protocol

Tissues were pulverized in liquid nitrogen and then lysed using NETN buffer (20 mM Tris–HCl, pH 8.0, 150 mM NaCl, 0.5 mM EDTA, 10% glycerol, and 0.5% NP-40). Protein concentration was determined by BCA Protein Assay Kit (Thermo Fisher, 23225). 1.5 mg of total protein lysate was used for IP. IP was performed by adding HA antibody (Cell Signaling, C29F4) or PA antibody (Fuji Film, NZ-1) to the lysate and incubate for 1 hr at 4°C. Subsequently, protein G magnetic beads (Thermo Fisher, 88847) were added for an additional 1 hr at 4°C. Then, the beads were washed five times with NETN buffer and denatured in sample buffer (Thermo Fisher, NP0007) for further analysis by western blot. For western blot procedures, briefly, denatured protein lysates were run on the 4 to 12%, Bis-Tris protein gels (Thermo Fisher, NP0321BOX) followed by electrophoretic transfer to nitrocellulose membrane. The membrane then went through blocking by 5% milk in Tris-buffered saline with Tween20 (TBST), followed by incubation overnight at 4°C in the primary antibodies anti-HA (Cell Signaling, C29F4), anti-PA (Fuji Film, NZ-1), anti-SMAD1 (Life Technologies, 385400), and anti-SMAD5 (ProteinTech, 12167-1-AP) at 1:1,000 dilution. The next day, membranes were washed three times with TBST, then incubated with horseradish peroxidase-conjugated secondary antibody for 1 hr at room temperature, then washed three times with TBST, developed and imaged on iBright Imaging System (FL1500).

Primary endometrial stromal cells isolation/RNAi/decidualization

Request a detailed protocol

Studies using human specimens were conducted as indicated in a protocol approved by the Institutional Review Board at Baylor College of Medicine, H-51900. Human EnSCs were collected from healthy volunteers’ menstrual effluent as previously reported (Warren et al., 2018; Nayyar et al., 2020; Martínez-Aguilar et al., 2020) (N = 3). In brief, samples were collected by participants in a DIVA cup during the 4–8 hr on the first night of menses and stored in DMEM/F12 with 10% FBS, antibiotic/antimycotic and 100 µg/ml Primocin in a cold-insulated pack until processing in the laboratory on the day of collection. The effluent was digested with 5 mg/ml collagenase and 0.2 mg/ml DNase I for 20 min at 37°C, then the cell pellet was collected by centrifuging at 2500 rpm for 5 min at room temperature. Next, red blood cell lysis was performed by resuspending the cell pellet in 20 ml of 0.2% NaCl for 20 s and neutralized with 20 ml of 1.6% NaCl. Then the solution was then centrifuged at 2500 rpm for 5 min. Then, 5 ml complete medium (DMEM/F12 supplement with 10% FBS, 1× Antibiotic-Antimycotic + 100 μg/ml Primocin) was used to resuspend the pellet and the solution was passed through 100 µm and 20 µm cell strainer sequentially. The flowthrough containing the stromal cells was centrifuged for 5 min at 2500 rpm and the pellet was resuspended in 10 ml complete medium and plated in a 10 cm dish. siRNA knockdown was performed using Lipofectamine RNAiMAX following the manufacturer’s protocol. In brief, 0.2 million stromal cells were plated in a 12-well plate 1 d before transfection. On the day of transfection, 2 µl siRNA (20 µM, Dharmacon, D-001810-10, L-012723-00-0005, L-015791-00-0005) and 3 µl Lipofectamine RNAiMAX were diluted in 50 µl Opti-MEM respectively and then mixed to incubate at room temperature for 15 min. Then, the complex was added dropwise onto the cells. Also, 24 hr after transfection, medium was changed to DMEM/F12 supplement with 2% charcoal-stripped FBS. Decidualization was induced by the addition of 35 nM estradiol (Sigma, E1024), 1 µM medroxyprogesterone (Sigma, 1378001), and 0.05 mM cyclic adenosine monophosphate (Axxora, JBS-NU-1502L) for 4 d with media changes every 48 hr.

RNA extraction and RT-qPCR

Request a detailed protocol

For mRNA extraction from stromal cells, cells were lysed with TRIzol and processed using the DirectZol kit (Zymo, R2051) following the manufacturer’s procedures. Approximately 100 ng of mRNA was reverse transcribed into cDNA using iScript cDNA Supermix (Bio-Rad, 1708890) and amplified using specific primers listed in Supplementary file 3a. Primers were amplified using 2× SYBR Green Reagent (Life Technologies, 4364346) using a Bio-Rad CFX384 Touch Real-Time PCR Detection System. Data analysis was performed by calculating ΔΔCT value toward the geometric mean of GAPDH, ACTB, and RPL13A and then normalized to siCTL. p-Value was determined by one-way ANOVA with post hoc Tukey test using GraphPad Prism. *p≤0.05, **p≤0.01, ***p≤0.001, ****p≤0.0001.

Data availability

Sequencing data and analyses are deposited in the Gene Expression Omnibus under accession number GSE237975.

The following data sets were generated
    1. Liao Z
    2. Tang S
    3. Nozawa K
    4. Shimada K
    5. Ikawa M
    6. Monsivais D
    7. Matzuk MM
    (2024) NCBI Gene Expression Omnibus
    ID GSE237975. Utilization of Tagged Transgenic Mouse Lines to Study the Molecular Roles of SMAD1/5 in Mediating Signaling Crosstalk During Early Pregnancy II.
    https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE237975
The following previously published data sets were used
    1. Yang M
    2. Ong J
    (2023) NCBI Gene Expression Omnibus
    ID 226417. Spatiotemporal insight into early pregnancy governed by immune-featured stromal cells [scRNA-seq].
    https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE226417
    1. Creighton C
    2. Chen F
    3. Monsivais D
    4. Matzuk M
    (2021) NCBI Gene Expression Omnibus
    ID 152675. Gene expression profiling of Smad1/5 cKO and Acvr2a cKO mice.
    https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE152675

References

    1. Martinez GM
    2. Daniels K
    3. Febo-Vazquez I
    (2018)
    Fertility of men and women aged 15-44 in the United States: National survey of family growth, 2011-2015
    National Health Statistics Reports 01:1–17.

Article and author information

Author details

  1. Zian Liao

    1. Department of Pathology & Immunology, Baylor College of Medicine, Houston, United States
    2. Graduate Program of Genetics and Genomics, Baylor College of Medicine, Houston, United States
    3. Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, United States
    4. Center for Drug Discovery, Baylor College of Medicine, Houston, United States
    Contribution
    Conceptualization, Formal analysis, Validation, Methodology, Writing – original draft
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7198-2182

  2. Suni Tang

    1. Department of Pathology & Immunology, Baylor College of Medicine, Houston, United States
    2. Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, United States
    Contribution
    Data curation, Investigation, Visualization, Methodology, Writing – review and editing
    Competing interests
    No competing interests declared

  3. Kaori Nozawa

    1. Department of Pathology & Immunology, Baylor College of Medicine, Houston, United States
    2. Center for Drug Discovery, Baylor College of Medicine, Houston, United States
    Contribution
    Data curation, Investigation, Methodology, Writing – review and editing
    Competing interests
    No competing interests declared

  4. Keisuke Shimada

    Research Institute for Microbial Diseases, Osaka University, Osaka, Japan
    Contribution
    Data curation, Methodology, Writing – review and editing
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3739-7163

  5. Masahito Ikawa

    Research Institute for Microbial Diseases, Osaka University, Osaka, Japan
    Contribution
    Resources, Project administration
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9859-6217

  6. Diana Monsivais

    1. Department of Pathology & Immunology, Baylor College of Medicine, Houston, United States
    2. Center for Drug Discovery, Baylor College of Medicine, Houston, United States
    Contribution
    Conceptualization, Supervision, Funding acquisition, Investigation, Writing – review and editing
    For correspondence
    diana.monsivais@bcm.edu
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5660-6392

  7. Martin Matzuk

    1. Department of Pathology & Immunology, Baylor College of Medicine, Houston, United States
    2. Graduate Program of Genetics and Genomics, Baylor College of Medicine, Houston, United States
    3. Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, United States
    4. Center for Drug Discovery, Baylor College of Medicine, Houston, United States
    Contribution
    Conceptualization, Supervision, Funding acquisition, Writing – review and editing
    For correspondence
    mmatzuk@bcm.edu
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1445-8632

Funding

Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD105800)

  • Diana Monsivais

Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD096057)

  • Diana Monsivais

Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD032067)

  • Martin Matzuk

Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD110038)

  • Martin Matzuk

Burroughs Wellcome Fund (NGP10125)

  • Diana Monsivais

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Acknowledgements

This research was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development grants HD105800 (DM), HD096057 (DM), HD032067 (MMM), and HD110038 (MMM). DM is supported by a Next Gen Pregnancy Award from the Burroughs Wellcome Fund (NGP10125).

Ethics

All mouse handling and experimental procedures were performed under the AN-716 protocol approved by the Institutional Animal Care and Use Committee of Baylor College of Medicine. Studies using human specimens were conducted as indicated in a protocol approved by the Institutional Review Board at Baylor College of Medicine, H-51900.

Version history

  1. Sent for peer review:
  2. Preprint posted:
  3. Reviewed Preprint version 1:
  4. Reviewed Preprint version 2:
  5. Reviewed Preprint version 3:
  6. Version of Record published:

Cite all versions

You can cite all versions using the DOI https://doi.org/10.7554/eLife.91434. This DOI represents all versions, and will always resolve to the latest one.

Copyright

© 2023, Liao et al.

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,319
    views
  • 117
    downloads
  • 1
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Zian Liao
  2. Suni Tang
  3. Kaori Nozawa
  4. Keisuke Shimada
  5. Masahito Ikawa
  6. Diana Monsivais
  7. Martin Matzuk
(2024)
Affinity-tagged SMAD1 and SMAD5 mouse lines reveal transcriptional reprogramming mechanisms during early pregnancy
eLife 12:RP91434.
https://doi.org/10.7554/eLife.91434.4

Share this article

https://doi.org/10.7554/eLife.91434

Categories and tags

Research organisms

Further reading

    1. Developmental Biology
    2. Genetics and Genomics

    Determining the effects of paternal obesity on sperm chromatin at histone H3 lysine 4 tri-methylation in relation to the placental transcriptome and cellular composition

    Anne-Sophie Pepin, Patrycja A Jazwiec ... Sarah Kimmins
    Research Article

    Paternal obesity has been implicated in adult-onset metabolic disease in offspring. However, the molecular mechanisms driving these paternal effects and the developmental processes involved remain poorly understood. One underexplored possibility is the role of paternally-induced effects on placenta development and function. To address this, we investigated paternal high-fat diet-induced obesity in relation to sperm histone H3 lysine 4 tri-methylation signatures, the placenta transcriptome and cellular composition. C57BL6/J male mice were fed either a control or high-fat diet for 10 weeks beginning at 6 weeks of age. Males were timed-mated with control-fed C57BL6/J females to generate pregnancies, followed by collection of sperm, and placentas at embryonic day (E)14.5. Chromatin immunoprecipitation targeting histone H3 lysine 4 tri-methylation (H3K4me3) followed by sequencing (ChIP-seq) was performed on sperm to define obesity-associated changes in enrichment. Paternal obesity corresponded with altered sperm H3K4me3 at promoters of genes involved in metabolism and development. Notably, sperm altered H3K4me3 was also localized at placental enhancers. Bulk RNA-sequencing on placentas revealed paternal obesity-associated sex-specific changes in expression of genes involved in hypoxic processes such as angiogenesis, nutrient transport, and imprinted genes, with a subset of deregulated genes showing changes in H3K4me3 in sperm at corresponding promoters. Paternal obesity was also linked to impaired placenta development; specifically, a deconvolution analysis revealed altered trophoblast cell lineage specification. These findings implicate paternal obesity-effects on placenta development and function as one potential developmental route to offspring metabolic disease.

    1. Developmental Biology
    2. Stem Cells and Regenerative Medicine

    Modeling corticotroph deficiency with pituitary organoids supports the functional role of NFKB2 in human pituitary differentiation

    Thi Thom Mac, Teddy Fauquier ... Thierry Brue
    Research Article

    Deficient Anterior pituitary with common Variable Immune Deficiency (DAVID) syndrome results from NFKB2 heterozygous mutations, causing adrenocorticotropic hormone deficiency (ACTHD) and primary hypogammaglobulinemia. While NFKB signaling plays a crucial role in the immune system, its connection to endocrine symptoms is unclear. We established a human disease model to investigate the role of NFKB2 in pituitary development by creating pituitary organoids from CRISPR/Cas9-edited human induced pluripotent stem cells (hiPSCs). Introducing homozygous TBX19K146R/K146R missense pathogenic variant in hiPSC, an allele found in congenital isolated ACTHD, led to a strong reduction of corticotrophs number in pituitary organoids. Then, we characterized the development of organoids harboring NFKB2D865G/D865G mutations found in DAVID patients. NFKB2D865G/D865G mutation acted at different levels of development with mutant organoids displaying changes in the expression of genes involved on pituitary progenitor generation (HESX1, PITX1, LHX3), hypothalamic secreted factors (BMP4, FGF8, FGF10), epithelial-to-mesenchymal transition, lineage precursors development (TBX19, POU1F1) and corticotrophs terminal differentiation (PCSK1, POMC), and showed drastic reduction in the number of corticotrophs. Our results provide strong evidence for the direct role of NFKB2 mutations in the endocrine phenotype observed in patients leading to a new classification of a NFKB2 variant of previously unknown clinical significance as pathogenic in pituitary development.

    1. Developmental Biology
    2. Genetics and Genomics

    ARID1A governs the silencing of sex-linked transcription during male meiosis in the mouse

    Debashish U Menon, Prabuddha Chakraborty ... Terry Magnuson
    Research Article

    We present evidence implicating the BAF (BRG1/BRM Associated Factor) chromatin remodeler in meiotic sex chromosome inactivation (MSCI). By immunofluorescence (IF), the putative BAF DNA binding subunit, ARID1A (AT-rich Interaction Domain 1 a), appeared enriched on the male sex chromosomes during diplonema of meiosis I. Germ cells showing a Cre-induced loss of ARID1A arrested in pachynema and failed to repress sex-linked genes, indicating a defective MSCI. Mutant sex chromosomes displayed an abnormal presence of elongating RNA polymerase II coupled with an overall increase in chromatin accessibility detectable by ATAC-seq. We identified a role for ARID1A in promoting the preferential enrichment of the histone variant, H3.3, on the sex chromosomes, a known hallmark of MSCI. Without ARID1A, the sex chromosomes appeared depleted of H3.3 at levels resembling autosomes. Higher resolution analyses by CUT&RUN revealed shifts in sex-linked H3.3 associations from discrete intergenic sites and broader gene-body domains to promoters in response to the loss of ARID1A. Several sex-linked sites displayed ectopic H3.3 occupancy that did not co-localize with DMC1 (DNA meiotic recombinase 1). This observation suggests a requirement for ARID1A in DMC1 localization to the asynapsed sex chromatids. We conclude that ARID1A-directed H3.3 localization influences meiotic sex chromosome gene regulation and DNA repair.